Correlation Between Regencell Bioscience and Dr Reddys

Can any of the company-specific risk be diversified away by investing in both Regencell Bioscience and Dr Reddys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regencell Bioscience and Dr Reddys into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regencell Bioscience Holdings and Dr Reddys Laboratories, you can compare the effects of market volatilities on Regencell Bioscience and Dr Reddys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regencell Bioscience with a short position of Dr Reddys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regencell Bioscience and Dr Reddys.

Diversification Opportunities for Regencell Bioscience and Dr Reddys

-0.39

Correlation Coefficient

Regencell Bioscience  Dr Reddys

Very good diversification

The 3 months correlation between Regencell and RDY is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Regencell Bioscience Holdings and Dr Reddys Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dr Reddys Laboratories and Regencell Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regencell Bioscience Holdings are associated (or correlated) with Dr Reddys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dr Reddys Laboratories has no effect on the direction of Regencell Bioscience i.e., Regencell Bioscience and Dr Reddys go up and down completely randomly.

Pair Corralation between Regencell Bioscience and Dr Reddys

Considering the 90-day investment horizon Regencell Bioscience Holdings is expected to under-perform the Dr Reddys. In addition to that, Regencell Bioscience is 3.61 times more volatile than Dr Reddys Laboratories. It trades about -0.25 of its total potential returns per unit of risk. Dr Reddys Laboratories is currently generating about 0.41 per unit of volatility. If you would invest  1,430  in Dr Reddys Laboratories on October 1, 2024 and sell it today you would earn a total of  156.00  from holding Dr Reddys Laboratories or generate 10.91% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Regencell Bioscience Holdings  vs.  Dr Reddys Laboratories

Regencell Bioscience

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Regencell Bioscience Holdings are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile technical and fundamental indicators, Regencell Bioscience may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Dr Reddys Laboratories

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dr Reddys Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Dr Reddys is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Regencell Bioscience and Dr Reddys

The main advantage of trading using opposite Regencell Bioscience and Dr Reddys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regencell Bioscience position performs unexpectedly, Dr Reddys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dr Reddys will offset losses from the drop in Dr Reddys' long position.

The idea behind Regencell Bioscience Holdings and Dr Reddys Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.